Filtros de búsqueda

Lista de obras de

A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme

artículo científico publicado en 2006

A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas

artículo científico publicado en 2008

A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas.

artículo científico publicado en 2009

A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma

artículo científico publicado en 2010

A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).

artículo científico publicado en 2008

A phase II study of extended low-dose temozolomide in recurrent malignant gliomas

artículo científico publicado en 2002

A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis

artículo científico publicado en 2008

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

artículo científico publicado en 2009

A phase II trial of oral gimatecan for recurrent glioblastoma

artículo científico publicado en 2012

A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases

artículo científico publicado en 2007

A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM).

artículo científico publicado en 2008

AT-18SURVIVAL ANALYSIS OF PATIENTS WITH A PFS EVENT WHO DID NOT RECEIVE POST-PROGRESSION THERAPY IN AVAGLIO (BEVACIZUMAB [BEV] PLUS RADIOTHERAPY [RT] AND TEMOZOLOMIDE [TMZ] FOR NEWLY DIAGNOSED GLIOBLASTOMA [GBM])

Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches

artículo científico publicado en 2011

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study

artículo científico publicado en 2012

BI-22CORRELATION OF MOLECULAR SUBTYPES WITH OVERALL SURVIVAL (OS) IN AVAGLIO, A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB (BEV) PLUS RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials

artículo científico publicado en 2016

Bcl-6 predicts improved prognosis in primary central nervous system lymphoma

artículo científico publicado en 2008

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma

artículo científico publicado en 2014

Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report

scientific article published on 25 October 2007

CNS Hodgkin lymphoma

artículo científico publicado en 2008

Capecitabine therapy of central nervous system metastases from breast cancer

artículo científico publicado en 2007

Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.

artículo científico publicado en 2010

Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up

artículo científico publicado en 2005

Chemotherapy and the treatment of brain metastases

artículo científico publicado en 2006

Chemotherapy for brain metastases: breast, gynecologic and non-melanoma skin malignancies.

artículo científico publicado en 2007

Chemotherapy for primary central nervous system lymphoma

artículo científico publicado en 2006

Clinical monograph: Clinical considerations for older patients with glioblastoma

artículo científico publicado en 2010

Cognitive functions in low-grade gliomas: disease and treatment effects.

artículo científico publicado en 2006

Cognitive functions in primary CNS lymphoma after single or combined modality regimens

artículo científico publicado en 2011

Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings.

artículo científico publicado en 2003

Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma

artículo científico publicado en 2007

Corticosteroid Use in Patients with Glioblastoma at First or Second Relapse Treated with Bevacizumab in the BRAIN Study ⬇️

artículo científico publicado el 8 de diciembre de 2010

Delayed neurotoxicity in primary central nervous system lymphoma

artículo científico publicado en 2005

Diagnosis and management of primary intraocular lymphoma: an update

artículo científico publicado en 2007

Diagnosis and treatment of primary central nervous system lymphoma

artículo científico publicado en 2005

Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials.

artículo científico publicado en 2017

Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007).

artículo científico publicado en 2009

HG-128BO25041 - A PHASE II OPEN-LABEL, RANDOMIZED, MULTI CENTRE COMPARATIVE STUDY OF BEVACIZUMAB BASED THERAPY IN PAEDIATRIC PATIENTS WITH NEWLY DIAGNOSED SUPRATENTORIAL, INFRATENTORIAL CEREBELLAR, OR PEDUNCULAR HIGH GRADE GLIOMA.

artículo científico publicado en 2016

High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib

artículo científico publicado en 2005

High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma.

artículo científico publicado en 2003

High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.

artículo científico publicado en 2006

High-grade gliomas in patients with prior systemic malignancies.

artículo científico publicado en 2002

Identifying and addressing barriers to the delivery of optimal therapy for primary central nervous system lymphoma in the broader community

artículo científico publicado en 2006

Imaging neurotoxicity: is a picture worth a thousand words?

artículo científico publicado en 2005

Initial treatment patterns over time for anaplastic oligodendroglial tumors

artículo científico publicado en 2012

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis

artículo científico publicado en 2003

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

artículo científico publicado en 2011

International study on low-grade primary central nervous system lymphoma

artículo científico publicado en 2006

Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma

artículo científico publicado en 2015

Intracranial dural metastases

artículo científico publicado en 2009

Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?

scientific article published on 01 June 2002

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

artículo científico publicado en 2011

LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma

artículo científico publicado en 2014

Late relapse in primary central nervous system lymphoma: clonal persistence

artículo científico publicado en 2011

Leptomeningeal metastases from leukemias and lymphomas

artículo científico publicado en 2005

Leukemic and lymphomatous meningitis: incidence, prognosis and treatment

artículo científico publicado en 2005

Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma

artículo científico publicado en 2006

Long-term survival in primary CNS lymphoma

artículo científico publicado en 1998

Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation

artículo científico publicado en 2019

Longitudinal cognitive follow-up in low grade gliomas.

artículo científico publicado en 2007

Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.

artículo científico publicado en 2011

Magnetic resonance spectroscopy imaging in radiotherapy planning for recurrent gliomaa)

artículo científico publicado en 2011

Maintenance therapy for central nervous system lymphoma with rituximab

artículo científico publicado en 2009

Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy

scientific article published on 24 June 2011

Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

artículo científico publicado en 2005

Multicenter Phase II Study of Temozolomide and Myeloablative Chemotherapy with Autologous Stem Cell Transplant for Newly Diagnosed Anaplastic Oligodendroglioma

artículo científico publicado en 2017

Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer

artículo científico publicado en 2015

Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma

artículo científico publicado en 2012

Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas.

artículo científico publicado en 2007

NI-36VALIDATION OF RANO CRITERIA: CONTRIBUTION OF T2/FLAIR ASSESSMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH BEVACIZUMAB.

artículo científico publicado en 2014

NIMG-01. DIFFUSION MRI PHENOTYPES PREDICT OVERALL SURVIVAL BENEFIT FROM ANTI-VEGF MONOTHERAPY IN GLIOBLASTOMA AT FIRST OR SECOND RELAPSE

artículo científico publicado en 2017

NIMG-53. POST-SURGICAL, RESIDUAL ENHANCING TUMOR VOLUME IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS

NIMG-84. TUMOR LOCATION IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab

artículo científico publicado en 2011

Neurological outcome of long-term glioblastoma survivors.

artículo científico publicado en 2009

Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.

artículo científico publicado en 2008

New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting

artículo científico publicado en 2005

Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment

scientific article published on 01 July 2004

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial

artículo científico publicado en 2015

Patterns of care in elderly glioblastoma patients

artículo científico publicado en 2008

Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma

artículo científico publicado en 2012

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

artículo científico publicado en 2009

Patterns of treatment in older adults with primary central nervous system lymphoma

artículo científico publicado en 2007

Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation

artículo científico publicado en 2009

Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy

artículo científico publicado en 2004

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma

scientific article published on 15 April 2020

Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma

artículo científico publicado en 2007

Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.

artículo científico publicado en 2017

Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.

artículo científico publicado en 2005

Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.

artículo científico publicado en 2006

Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02

scientific article published on 01 January 2020

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.

artículo científico publicado en 2012

Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.

artículo científico publicado en 2014

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

artículo científico publicado en 2009

Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma

scientific article published on 19 July 2019

Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma

artículo científico publicado en 2012

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).

artículo científico publicado en 2010

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

artículo científico publicado en 2014

Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.

artículo científico publicado en 2006

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.

artículo científico publicado en 2009

Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma.

artículo científico publicado en 2018

Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo

artículo científico publicado en 2018

Post-treatment T1 shortening in primary CNS lymphoma.

artículo científico publicado en 2012

Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).

artículo científico publicado en 2011

Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group

artículo científico publicado en 2005

Primary central nervous system lymphoma

artículo científico publicado en 2004

Primary central nervous system lymphoma

scientific article published on 01 July 2007

Primary central nervous system lymphoma

artículo científico publicado en 2007

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

artículo científico publicado en 2006

Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.

artículo científico publicado en 2008

Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients

scientific article published on 01 June 2006

Primary dural lymphomas: a review

artículo científico publicado en 2006

Prognosis and patterns of care in elderly patients with glioma

artículo científico publicado en 2009

Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials

artículo científico publicado en 2013

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas

artículo científico publicado en 2008

Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy

artículo científico publicado en 2008

Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.

artículo científico publicado en 2005

Quantitative Imaging Biomarkers for Risk Stratification of Patients with Recurrent Glioblastoma Treated with Bevacizumab

artículo científico publicado en 2017

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

artículo científico publicado en 2015

Racial differences in primary central nervous system lymphoma incidence and survival rates

artículo científico publicado en 2009

Radiologic progression of glioblastoma under therapy - an exploratory analysis of AVAglio

artículo científico publicado en 2017

Radiotherapy and temozolomide for anaplastic astrocytic gliomas.

artículo científico publicado en 2015

Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma

artículo científico publicado en 2009

Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older

artículo científico publicado en 2012

Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors

artículo científico publicado en 2014

Reply to T.J. Kruser et al.

artículo científico publicado en 2016

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

artículo científico publicado en 2005

Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD).

artículo científico publicado en 2014

Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab ⬇️

artículo científico publicado el 17 de noviembre de 2010

Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy.

artículo científico publicado en 2013

Response of glioblastomas to EGFR kinase inhibitors

artículo científico publicado en 2006

Response to Weltman and Fleury Malheiros, re Lassman et al.

artículo científico publicado en 2012

Retinopathy in survivors of primary central nervous system lymphoma

artículo científico publicado en 2006

Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome

artículo científico publicado en 2013

Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas

artículo científico publicado en 2009

Salvage temozolomide for prior temozolomide responders

artículo científico publicado en 2005

Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide

artículo científico publicado en 2004

Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma

artículo científico publicado en 2007

Sarcoidosis of the cauda equina mimicking leptomeningeal malignancy

scientific article published on 01 September 1998

Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas

artículo científico publicado en 2011

Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma

artículo científico publicado en 2002

Strategies to advance translational research into brain barriers

artículo científico publicado en 2008

Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma

scientific article published on 01 December 2007

Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002.

artículo científico publicado en 2003

Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme

artículo científico publicado en 2009

Survey of treatment recommendations for anaplastic oligodendroglioma

artículo científico publicado en 2007

Survival in elderly glioblastoma patients treated with bevacizumab-based regimens in the United States

scientific article published on 06 February 2018

Synchronous presentation of systemic and brain non-Hodgkin lymphoma

artículo científico publicado en 2008

Systemic high-dose intravenous methotrexate for central nervous system metastases

scientific article published on 01 July 2006

Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium

artículo científico publicado en 2002

The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab

artículo científico publicado en 2015

The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma

artículo científico publicado en 2004

The utility of body FDG PET in staging primary central nervous system lymphoma

artículo científico publicado en 2008

Therapeutic challenges in primary CNS lymphoma

artículo científico publicado en 2009

Treatment of brain metastases: a short review of current therapies and the emerging role of temozolomide.

artículo científico publicado en 2003

Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma

artículo científico publicado en 2008

Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.

artículo científico publicado en 2004

Treatment-related neurotoxicity

artículo científico publicado en 2005

Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis

artículo científico publicado en 2005

Unraveling molecular markers of biologic therapies in glioma.

artículo científico publicado en 2006

Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio

artículo científico publicado en 2016

Utility of brain FDG-PET in primary CNS lymphoma

artículo científico publicado en 2008

Validation of post-operative residual contrast enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.

artículo científico publicado en 2018

YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda